Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;11(3):181-186.
doi: 10.5114/pg.2016.57734. Epub 2016 Feb 8.

Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia

Jarosław Szefel  1 , Wiesław J Kruszewski  1 , Mariusz Szajewski  1 , Maciej Ciesielski  1 , Ewa Sobczak  2 , Maksymilian Czerepko  3 , Wiesława Łysiak-Szydłowska  4
Affiliations

Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia

Jarosław Szefel et al. Prz Gastroenterol. 2016.

Abstract

Introduction: Currently there are no established guidelines regarding the use of long-chain triglycerides (LCT) vs. medium-chain triglycerides medium-chain triglycerides (MCT)/long-chain triglycerides (LCT) in total parenteral nutrition (TPN). Severe malnutrition of patients with refractory cachexia (RC) often causes their disqualification from invasive methods of treatment thus decreasing their quality of life and survival time.

Aim: To compare the changes in nutritional state of patients with RC receiving PN with LCT and LCT/MCT lipid emulsions and to assess the influence of enteral nutrition on their survival time.

Material and methods: The study group comprised of 50 patients (23 female, 27 male) with a median age of 66 years. Refractory cachexia was diagnosed in them due to dysphagia secondary to solid tumours causing obstruction of the gastrointestinal tract (GT). All patients were qualified for surgical gastrostomy due to contraindications to percutaneous endoscopic gastrostomy. The patients were randomly assigned into one of two groups and perioperatively received either LCT or LCT/MCT. Blood samples were collected four times and tested for: total protein, albumin, prealbumin, and C-reactive protein concentration. Patients received Home Enteral Nutrition after discharge from hospital.

Results: Changes in nutritional status parameters were similar among patients receiving lipid emulsions LCT vs. MCT/LCT in TPN for 11 days. The mean survival time of all patients operated to gain enteral access to nutrition was 192 ±268 days, and the median survival was 98 days.

Conclusions: Regarding the short-term TPN, the results of the study do not demonstrate any superiority of MCT/LCT lipid emulsions over LCT, or vice versa. The inability to eat significantly accelerates unintended body mass loss among patients with RC. Disqualification from invasive treatment options deprives some patients of the benefits they might have obtained from the surgical access to GT and enteral nutrition.

Keywords: long-chain triglycerides; medium-chain triglycerides; refractory cachexia; survival time.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
The Kaplan-Meier survival estimates for the patients with CRP < 10 mg/l and CRP > 10 mg/l on the day of admission
Figure 2
Figure 2
The Kaplan-Meier survival estimates for the patients with BML < 10% and BML > 10% in the 6 months prior to hospitalisation
See this image and copyright information in PMC

References

    1. WHO: WHO Definition of Palliative Care. [(accessed on 21 December 2012)]. Available online: http://www.who.int/cancer/palliative/definition/en/
    1. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95. - PubMed
    1. Marin Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007;26:289–301. - PubMed
    1. Bachmann P, Marti-Massoud C, Blanc-Vincent MP, et al. Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001) Br J Cancer. 2003;89(Suppl. 1):S107–10. - PMC - PubMed
    1. Oh do Y, Kim JH, Lee SH, et al. Artificial nutrition and hydration in terminal cancer patients: the real and the ideal. Support Care Cancer. 2007;15:631–6. - PubMed